How the Swiss enter the US market with a variety of rich cannabigerol
The relatively low amount of cannabigerol found in hemp means that even small amounts of the compound require a huge amount of biomass to isolate , which initially implies high prices for the end user . That is why cannabigerol extract is called the “Rolls-Royce of cannabinoids” because of the expensive manufacturing process . Ukrainian breeders can boast of their achievements in solving problems aimed at obtaining varieties of technical hemp rich in cannabigerol . For a not very long time in Ukraine it is planned toregistration is another therapeutic hemp variety rich in the above drug-free cannabinoid.
The pages of the profile electronic publication of Ukrainian hemp breeders have already raised the question that " Cannabigerol is a new milestone in cannabinoid medicine ." How relevant is the creation of technical hemp varieties of therapeutic orientation rich in melon drug-free cannabinoid in our country, we will try to understand this material.
The American company "High Grade Hemp Seed" produces and distributes cannabishera with a high content of cannigerol developed in Switzerland in the United States . The cannabis variety “Matterhorn” was developed by the Swiss company “Swiss Cannabinoid” in cooperation with European geneticists in the interests of international pharmacological companies. “Matterhorn” is registered in the USA through the mediation of the research company “Phylos Galaxy”. As part of the registration of this variety, ten licensed agricultural producers were provided with 2000 seeds each so that they could test the above varieties rich in cannabigerol in their region (climatic zone).
Drug-Free Cannabinoid Cannabigerol (CBG) is one of 120 cannabinoids found in hemp . It was first obtained in the 60s of the last century. Not included in international drug lists and is not considered a controlled substance . CBG is known as the “maternal” cannabinoid because it is a precursor of a significant amount of other cannabinoids, such as cannabidiol, cannabinol, cannabichromene, tetrahydrocannabinol acid, etc. The mechanism of action of cannabigerol on the human body is that this drug-free cannabinoid activates CB1 and CB2 receptors in endocannabinoid system. It is believed that CBG is capable of containing a combination of a number of therapeutic properties of other cannabinoids .
Despite the fact that while clinical trials of cannabigerol are catastrophically inadequate, some studies suggest that the above drug-free cannabinoid can be effectively used to treat a large group of eye diseases (e.g. glaucoma), inflammation of the digestive system, and genetic diseases (e.g. Huntington's syndrome), inhibition of cancer cells ( treatment of cancer ), slowing the development of bacteria, in the treatment of various kinds of neurodegenerative diseases, and also contributes to the development of bone tissue and the healing / treatment of various skin problems .
Commentary experts of the Association " Ukrainian industrial hemp "
The relatively low amount of cannabigerol found in hemp means that even small amounts of the compound require a huge amount of biomass to isolate , which initially implies high prices for the end user . That is why cannabigerol extract is called the “Rolls-Royce of cannabinoids” because of the expensive manufacturing process . Ukrainian breeders can boast of their achievements in solving problems aimed at obtaining varieties of technical hemp rich in cannabigerol . For a not very long time in Ukraine, it is planned to register one more variety of technical hemp of a therapeutic orientation, rich in the above drug-free cannabinoid.